Poultry Trials

Productivity gains obtained with OxC-beta in healthy broiler chickens

Productivity gains obtained with OxC-beta in healthy broiler chickens*

Results above are based on a single 39-day trial with 2,500 birds divided equally into 5 treatments. Bars denote % improvements relative to un-supplemented controls. *= p < 0.05

Across multiple studies evaluating OxC-beta’s growth promoting efficacy in healthy broilers it was found that use of OxC-beta at feed inclusion rates at or above 2 ppm had consistent and statistically significant benefits on measures of broiler performance.

OxC-beta has been shown to improve ADG, FBW and FCR by 3 to 4% in healthy birds.

In a 2006 Canadian study of healthy broilers, involving a total of 500 birds per group, it was established that dose rates of OxC-beta as low as 2ppm, were effective in improving final body weights and feed conversion efficiency relative to un-supplemented controls.

Most notably the birds in the 2ppm and 5ppm OxC-beta supplemented groups performed better than those receiving a standard antibiotic growth promoter (**).

Challenge Conditions: Necrotizing Enteritis

Necrotic enteritis (NE), a disease caused by the bacteria Clostridium perfringens poses a significant challenge in maintaining health and competitive growth rates. Prevention of disease is vital but in many countries local regulations prohibit the use of antibiotics. OxC-beta provides a viable alternative to antibiotics and a valuable tool for maintaining healthy profits.

Mode of Action

In a recent (2014) subacute necrotic enteritis challenge trial in Korea birds receiving OxC-beta performed comparably to birds receiving prophylactic antibiotic growth promoter (Methylene disalicylate (BMD) at 55 ppm in the feed). These results are consistent with an earlier Canadian NE challenge trial, which also demonstrated that birds receiving OxC-beta performed on par with those receiving standard antibiotic growth promoter.

The results to date clearly demonstrate that OxC-beta is a viable alternative to prophylactic antibiotics in poultry under production conditions.

Average Daily Gain


CFU Counts


Lesion Score


** Data on File